Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Confirming the MS diagnosis.

A Garcia Merino1, M R Blasco

  • 1Neuroimmunology Unit, Servicio de Neurologia, Hospital Puerta de Hierro, Universidad Autonoma de Madrid, San Martin de Porres, 4, 28035 Madrid, Spain. gmerino@meditex.es

International MS Journal
|August 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Neurologia·2022
Same author

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Neurologia·2020
Same author

Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016.

Neurologia (Barcelona, Spain)·2016
Same author

Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.

The European journal of health economics : HEPAC : health economics in prevention and care·2013
Same author

Diet and prevalence of atopic eczema in 6 to 7-year-old schoolchildren in Spain: ISAAC phase III.

Journal of investigational allergology & clinical immunology·2011
Same author

Monoclonal antibodies. Basic features.

Neurologia (Barcelona, Spain)·2011
Same journal

American academy of neurology annual meeting.

International MS journal·2011
Same journal

Tumour Necrosis Factor Neutralization in MS: A Cautionary Tale.

International MS journal·2011
Same journal

The clinical usefulness of routine MRI assessment.

International MS journal·2011
Same journal

Acute Psychosis as the Initial Presentation of MS: A Case Report.

International MS journal·2011
Same journal

Russell Brains Review of MS.

International MS journal·2011
Same journal

Epstein-Barr Virus and MS:Causality or Association?

International MS journal·2011
See all related articles

Early diagnosis of multiple sclerosis (MS) is crucial for preventing irreversible central nervous system damage. Utilizing updated diagnostic criteria, including magnetic resonance imaging, allows for earlier identification and treatment of MS.

Area of Science:

  • Neurology
  • Neuroimmunology
  • Central Nervous System Disorders

Background:

  • Irreversible central nervous system (CNS) damage in multiple sclerosis (MS) can occur early in the disease.
  • Early use of disease-modifying drugs may prevent some of this damage.
  • Timely diagnosis of MS is therefore critical for effective management.

Purpose of the Study:

  • To review the diagnostic evaluation process for patients with suspected multiple sclerosis.
  • To highlight the importance of early MS diagnosis in light of current pathophysiological understanding.

Main Methods:

  • Review of diagnostic criteria for MS, focusing on dissemination in space and time.
  • Inclusion of magnetic resonance imaging (MRI) definitions within the McDonald criteria.

Related Experiment Videos

  • Discussion of the steps involved in evaluating patients with suspected MS.

    • Main Results:

    • Diagnostic criteria for MS incorporate definitions for dissemination in space and time.
    • The McDonald criteria utilize MRI for these definitions, enabling earlier diagnosis.
    • Earlier diagnosis facilitates prompt initiation of disease-modifying therapies.

    Conclusions:

    • Early diagnosis of MS is essential to mitigate irreversible neurological damage.
    • Current diagnostic criteria, particularly the McDonald criteria with MRI, support earlier MS detection.
    • Prompt diagnosis enables timely intervention with disease-modifying drugs, improving patient outcomes.